Israel: Market for Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof 2024

Market Size for Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof in Israel

The Israeli penicillins or streptomycins medicaments market amounted to $X in 2022, with an increase of 3.9% against the previous year. Over the period under review, consumption saw perceptible growth. Penicillins or streptomycins medicaments consumption peaked at $X in 2017; however, from 2018 to 2022, consumption stood at a somewhat lower figure.

Production of Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof in Israel

In value terms, penicillins or streptomycins medicaments production totaled $X in 2022 estimated in export price. Over the period under review, production, however, saw a strong increase. The pace of growth was the most pronounced in 2014 with an increase of 353%. Over the period under review, production reached the peak level at $X in 2017; however, from 2018 to 2022, production remained at a lower figure.

Exports of Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof

Exports from Israel

For the fourth consecutive year, Israel recorded growth in overseas shipments of medicaments of penicillins, streptomycins or derivatives thereof, which increased by 57% to X tons in 2022. Overall, exports enjoyed measured growth. The pace of growth was the most pronounced in 2019 when exports increased by 188% against the previous year. The exports peaked in 2022 and are expected to retain growth in the immediate term.

In value terms, penicillins or streptomycins medicaments exports surged to $X in 2022. Over the period under review, exports saw a modest increase. The growth pace was the most rapid in 2016 with an increase of 307% against the previous year. The exports peaked in 2022 and are likely to see steady growth in years to come.

Exports by Country

Latvia (X tons) was the main destination for penicillins or streptomycins medicaments exports from Israel, accounting for a approx. 98% share of total exports.

From 2012 to 2022, the average annual rate of growth in terms of volume to Latvia totaled +1,746.9%.

In value terms, Latvia ($X) emerged as the key foreign market for medicaments of penicillins, streptomycins or derivatives thereof exports from Israel.

From 2012 to 2022, the average annual growth rate of value to Latvia totaled +1,920.9%.

Export Prices by Country

The average penicillins or streptomycins medicaments export price stood at $X per ton in 2022, reducing by -5.6% against the previous year. Overall, the export price showed a mild downturn. The pace of growth appeared the most rapid in 2016 when the average export price increased by 46%. Over the period under review, the average export prices reached the peak figure at $X per ton in 2017; however, from 2018 to 2022, the export prices failed to regain momentum.

As there is only one major export destination, the average price level is determined by prices for Latvia.

From 2012 to 2022, the rate of growth in terms of prices for Latvia amounted to +9.4% per year.

Imports of Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof

Imports into Israel

In 2022, the amount of medicaments of penicillins, streptomycins or derivatives thereof imported into Israel surged to X tons, increasing by 55% on the year before. In general, imports, however, continue to indicate a noticeable curtailment. The pace of growth appeared the most rapid in 2019 with an increase of 329%. Imports peaked at X tons in 2013; however, from 2014 to 2022, imports stood at a somewhat lower figure.

In value terms, penicillins or streptomycins medicaments imports skyrocketed to $X in 2022. Overall, imports, however, continue to indicate a pronounced setback. The pace of growth was the most pronounced in 2019 when imports increased by 266% against the previous year. Imports peaked at $X in 2013; however, from 2014 to 2022, imports failed to regain momentum.

Imports by Country

In 2022, France (X tons) constituted the largest supplier of penicillins or streptomycins medicaments to Israel, accounting for a 50% share of total imports. Moreover, penicillins or streptomycins medicaments imports from France exceeded the figures recorded by the second-largest supplier, India (X tons), twofold. The third position in this ranking was held by Italy (X tons), with an 8% share.

From 2012 to 2022, the average annual growth rate of volume from France stood at +13.0%. The remaining supplying countries recorded the following average annual rates of imports growth: India (+7.2% per year) and Italy (+10.3% per year).

In value terms, France ($X) constituted the largest supplier of medicaments of penicillins, streptomycins or derivatives thereof to Israel, comprising 50% of total imports. The second position in the ranking was taken by India ($X), with a 24% share of total imports. It was followed by Italy, with an 8% share.

From 2012 to 2022, the average annual growth rate of value from France totaled +18.2%. The remaining supplying countries recorded the following average annual rates of imports growth: India (+10.1% per year) and Italy (+5.6% per year).

Import Prices by Country

The average penicillins or streptomycins medicaments import price stood at $X per ton in 2022, shrinking by -7.5% against the previous year. In general, the import price, however, recorded a relatively flat trend pattern. The most prominent rate of growth was recorded in 2018 when the average import price increased by 13% against the previous year. As a result, import price reached the peak level of $X per ton. From 2019 to 2022, the average import prices remained at a lower figure.

Average prices varied noticeably amongst the major supplying countries. In 2022, amid the top importers, the highest price was recorded for prices from Italy ($X per ton) and the UK ($X per ton), while the price for the Netherlands ($X per ton) and Germany ($X per ton) were amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by France (+4.6%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :